scPharmaceuticals (SCPH) - 2020 Q1 - Quarterly Report

For the transition period from to Commission file number: 001-38293 UNITED STATES SECURITIES AND EXCHANGE COMMISSION SCPHARMACEUTICALS INC. Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Zip Code) Registrant's telephone number, including area code: (617) 517-0730 Securities registered pursuant ...